This study is looking at a diagnostic test called ICG (Indocyanine Green) to help doctors find lymph nodes in children with solid tumors. ICG is a special dye that helps light up lymph nodes during surgery. The goal is to see how well and safely ICG can help find these lymph nodes in pediatric patients (under 18 years old) who need lymph node sampling as part of their cancer care. This study is for children being treated at the University of Rochester Medical Center who have a pediatric solid tumor like rhabdomyosarcoma, sarcoma, or germ cell tumor. The main thing they are measuring is the percentage of patients where ICG successfully helps find the sentinel lymph node (the first lymph node to which cancer cells are likely to spread). The study's current status is unclear.

Study design

This is an observational study with a planned enrollment of 10 participants. It is a single-site, cross-sectional study.

What's involved

You would receive an injection of ICG directly into the lymphatics draining the primary tumor during your operation, after you are under anesthesia.

Compensation

Not stated in the trial record.

Follow-up

The primary endpoint is measured at Baseline, which is at the time of the procedure.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.